Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome
Clinical trial NCT01289457 · COMPLETED
Trial details
- NCT number
- NCT01289457
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-02
- Primary completion
- 2017-06-28
- Enrollment
- 282
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.